These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31294649)

  • 1. Adjunctive minocycline for major mental disorders: A systematic review.
    Zheng W; Zhu XM; Zhang QE; Cheng G; Cai DB; He J; Ng CH; Ungvari GS; Peng XJ; Ning YP; Xiang YT
    J Psychopharmacol; 2019 Oct; 33(10):1215-1226. PubMed ID: 31294649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive folate for major mental disorders: A systematic review.
    Zheng W; Li W; Qi H; Xiao L; Sim K; Ungvari GS; Lu XB; Huang X; Ning YP; Xiang YT
    J Affect Disord; 2020 Apr; 267():123-130. PubMed ID: 32063563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials.
    Zheng W; Zhu XM; Zhang QE; Cai DB; Yang XH; Zhou YL; Ungvari GS; Ng CH; He SH; Peng XJ; Ning YP; Xiang YT
    Schizophr Res; 2019 Jul; 209():12-21. PubMed ID: 31164254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials.
    Zheng W; Zhang QE; Cai DB; Yang XH; Qiu Y; Ungvari GS; Ng CH; Berk M; Ning YP; Xiang YT
    Acta Psychiatr Scand; 2018 May; 137(5):391-400. PubMed ID: 29457216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.
    Fond G; Hamdani N; Kapczinski F; Boukouaci W; Drancourt N; Dargel A; Oliveira J; Le Guen E; Marlinge E; Tamouza R; Leboyer M
    Acta Psychiatr Scand; 2014 Mar; 129(3):163-79. PubMed ID: 24215721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.
    Solmi M; Veronese N; Thapa N; Facchini S; Stubbs B; Fornaro M; Carvalho AF; Correll CU
    CNS Spectr; 2017 Oct; 22(5):415-426. PubMed ID: 28181901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
    Zheng W; Cai DB; Zhang QE; He J; Zhong LY; Sim K; Ungvari GS; Ning YP; Xiang YT
    J Psychiatr Res; 2019 Jun; 113():27-33. PubMed ID: 30878789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.
    Xiang YQ; Zheng W; Wang SB; Yang XH; Cai DB; Ng CH; Ungvari GS; Kelly DL; Xu WY; Xiang YT
    Eur Neuropsychopharmacol; 2017 Jan; 27(1):8-18. PubMed ID: 27919523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Oya K; Kishi T; Iwata N
    Hum Psychopharmacol; 2014 Sep; 29(5):483-91. PubMed ID: 25087702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline for Depressive Symptoms: a Meta-Analysis of Randomized, Double-Blinded, Placebo-Controlled Trials.
    Cai DB; Zheng W; Zhang QE; Ng CH; Ungvari GS; Huang X; Xiang YT
    Psychiatr Q; 2020 Jun; 91(2):451-461. PubMed ID: 31965454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials.
    Köhler-Forsberg O; N Lydholm C; Hjorthøj C; Nordentoft M; Mors O; Benros ME
    Acta Psychiatr Scand; 2019 May; 139(5):404-419. PubMed ID: 30834514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
    Kishi T; Miyake N; Okuya M; Sakuma K; Iwata N
    Psychopharmacology (Berl); 2020 Nov; 237(11):3481-3487. PubMed ID: 32767039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Cai DB; Yang XH; Ungvari GS; Ng CH; Müller N; Ning YP; Xiang YT
    J Psychiatr Res; 2017 Sep; 92():139-146. PubMed ID: 28445800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
    Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
    Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis: Traitement Pharmacologique des Troubles de L'humeur et des Dépendances Comorbides: Une Revue Systématique et une Méta-Analyse.
    Stokes PRA; Jokinen T; Amawi S; Qureshi M; Husain MI; Yatham LN; Strang J; Young AH
    Can J Psychiatry; 2020 Nov; 65(11):749-769. PubMed ID: 32302221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.
    Lao KS; He Y; Wong IC; Besag FM; Chan EW
    CNS Drugs; 2016 Nov; 30(11):1043-1054. PubMed ID: 27550371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive continuous theta burst stimulation for major depressive disorder or bipolar depression: A meta-analysis of randomized controlled studies.
    Cai DB; Qin XD; Qin ZJ; Lan XJ; Wang JJ; Ng CH; Zheng W; Xiang YT
    J Affect Disord; 2024 Feb; 346():266-272. PubMed ID: 37924984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
    Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.